MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer

被引:158
作者
Qiu, Tianzhu [1 ]
Zhou, Xin [1 ]
Wang, Jian [1 ]
Du, Yiping [1 ]
Xu, Jun [1 ]
Huang, Zebo [1 ]
Zhu, Wei [1 ]
Shu, Yongqian [1 ]
Liu, Ping [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing 210029, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Gastric cancer; miR-145; miR-133a; miR-133b; Proliferation; Migration; Invasion; Cell cycle progression; Sp1; COLORECTAL-CANCER; HUMAN GLIOMA; EXPRESSION; GROWTH; SURVIVAL; METASTASIS; MICRORNA; OVEREXPRESSION; SUPPRESSOR; MECHANISM;
D O I
10.1016/j.febslet.2014.02.054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs have recently emerged as key regulators of gastric cancers. Here we found that miR-145, miR-133a and miR-133b were down-regulated in gastric cancer tissues and cell lines. Overexpression of miR-145, miR-133a and miR-133b induced G1 cell cycle arrest and inhibited cell proliferation, migration and invasion in vitro. MiR-145, miR-133a and miR-133b targeted the transcription factor SP1, knockdown of which reduced the expression of MMP-9 and Cyclin D1 that were involved in cell growth and invasion. Thus, our findings demonstrated for the first time that miR-145, miR-133a and miR-133b suppressed the proliferation, migration, invasion and cell cycle progression of gastric cancer cells through decreasing expression of Sp1 and its downstream proteins. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1168 / 1177
页数:10
相关论文
共 47 条
  • [1] The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients
    Avgeris, M.
    Stravodimos, K.
    Fragoulis, E. G.
    Scorilas, A.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (12) : 2573 - 2581
  • [2] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [3] Bottou L., 2012, Neural Networks: Tricks of the Trade, V7700, P421, DOI 10.1007/978-3-642-35289-8_25
  • [4] Molecular biology of gastric carcinoma: From laboratory to bedside
    Chan, AOO
    Luk, JMC
    Hui, WM
    Lam, SK
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (12) : 1150 - 1160
  • [5] Overexpression of HDAC1 induces cellular senescence by Sp1/PP2A/pRb pathway
    Chuang, Jian-Ying
    Hung, Jan-Jong
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (03) : 587 - 592
  • [6] A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel
    Du, Liqin
    Borkowski, Robert
    Zhao, Zhenze
    Ma, Xiuye
    Yu, Xiaojie
    Xie, Xian-Jin
    Pertsemlidis, Alexander
    [J]. RNA BIOLOGY, 2013, 10 (11) : 1700 - 1713
  • [7] miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression
    Duan, Fang-Ting
    Qian, Feng
    Fang, Ke
    Lin, Kang-Yu
    Wang, Wen-Tao
    Chen, Yue-Qin
    [J]. MOLECULAR CANCER, 2013, 12
  • [8] Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome
    Guan, Hongyu
    Cai, Junchao
    Zhang, Nu
    Wu, Jueheng
    Yuan, Jie
    Li, Jun
    Li, Mengfeng
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (03) : 593 - 601
  • [9] miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor
    Guo, Jinling
    Xia, Bairong
    Meng, Fanling
    Lou, Ge
    [J]. TUMOR BIOLOGY, 2014, 35 (02) : 1557 - 1564
  • [10] miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1
    Guo, Mei-Mei
    Hu, Li-Hua
    Wang, Yong-Qiang
    Chen, Peng
    Huang, Jian-Guo
    Lu, Ning
    He, Jiang-Hong
    Liao, Cheng-Gong
    [J]. MEDICAL ONCOLOGY, 2013, 30 (02)